Discussion on the Situation of Drug Production Inspection and Supervision Strategy under the Requirements of New Laws and Regulations

Wang Dan, Ouyang Nan, Chen Ying

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (6) : 611-615.

Chinese Pharmaceutical Affairs ›› 2022, Vol. 36 ›› Issue (6) : 611-615. DOI: 10.16153/j.1002-7777.2022.06.002
Supervision Administration

Discussion on the Situation of Drug Production Inspection and Supervision Strategy under the Requirements of New Laws and Regulations

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 36(6): 611-615 https://doi.org/10.16153/j.1002-7777.2022.06.002

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail
Sections
Recommended
京ICP备17052540号-4
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉